Comparison between Avience Biomedicals IPO and Grand Continent Hotels IPO.
Avience Biomedicals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Grand Continent Hotels IPO is a SME Bookbuilding proposed to list at NSE SME.
| Avience Biomedicals IPO | Grand Continent Hotels IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Indorient Financial Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹28.53 Cr whereas the issue size of the Grand Continent Hotels IPO is up to ₹70.73 Cr. The final issue price of Avience Biomedicals IPO is ₹208.00 per share and of Grand Continent Hotels IPO is ₹113.00 per share.
| Avience Biomedicals IPO | Grand Continent Hotels IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹196.00 per share | ₹107.00 per share |
| Issue Price (Upper) | ₹208.00 per share | ₹113.00 per share |
| Issue Price (Final) | ₹208.00 per share | ₹113.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 600 shares | 1200 shares |
| Fresh Issue Size | 13,71,600 shares | 59,30,400 shares |
| Fresh Issue Size (Amount) | up to ₹28.53 Cr | up to ₹67.01 Cr |
| OFS Issue Size | 0 shares | 3,28,800 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹3.72 Cr |
| Issue Size Total | 13,71,600 shares | 62,59,200 shares |
| Issue Size Total (Amount) | up to ₹28.53 Cr | up to ₹70.73 Cr |
Avience Biomedicals IPO opens on Jun 18, 2026, while Grand Continent Hotels IPO opens on Mar 20, 2025. The closing date of Avience Biomedicals IPO and Grand Continent Hotels IPO is Jun 22, 2026, and Mar 24, 2025, respectively.
| Avience Biomedicals IPO | Grand Continent Hotels IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2026 | Mar 19, 2025 |
| Issue Open | Jun 18, 2026 | Mar 20, 2025 |
| Issue Close | Jun 22, 2026 | Mar 24, 2025 |
| Basis Of Allotment (Tentative) | Jun 23, 2026 | Mar 25, 2025 |
| Initiation of Refunds (Tentative) | Jun 24, 2026 | Mar 26, 2025 |
| Credit of Share (Tentative) | Jun 24, 2026 | Mar 26, 2025 |
| Listing date (Tentative) | Jun 25, 2026 | Mar 27, 2025 |
| Anchor Lockin End date 1 | Jul 23, 2026 | Apr 24, 2025 |
| Anchor Lockin End date 2 | Sep 21, 2026 | Jun 23, 2025 |
Avience Biomedicals IPO P/E ratio is 11.59, as compared to Grand Continent Hotels IPO P/E ratio of 51.24.
| Avience Biomedicals IPO | Grand Continent Hotels IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.89 | 75.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.59 | 54.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.59 | 51.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹114.09 Cr. | ₹281.59 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | 17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | 1.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹17.94 | ₹2.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 49.89 | 26.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 4,81,200 shares while in Grand Continent Hotels IPO retail investors are offered 4,81,200 shares. Qualified Institutional Buyers (QIB) are offered 2,73,600 shares in Avience Biomedicals IPO and 12,49,200 shares in Grand Continent Hotels IPO.
| Avience Biomedicals IPO | Grand Continent Hotels IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,09,800 shares | 18,73,200 shares |
| Market Maker Reservation | 82,200 shares | 3,30,000 shares |
| QIB | 2,73,600 shares | 12,49,200 shares |
| NII | 2,07,000 shares | 9,37,200 shares |
| RII | 4,81,200 shares | 21,87,600 shares |
| Employee | 0 shares | 12,000 shares |
| Others | ||
| Total | 13,71,600 shares | 62,59,200 shares |
Avience Biomedicals IPO subscribed 270.19x in total, whereas Grand Continent Hotels IPO subscribed 1.26x.
| Avience Biomedicals IPO | Grand Continent Hotels IPO | |
|---|---|---|
| QIB (times) | 196.77x | 2.93x |
| NII (times) | 597.23x | 1.39x |
| Big NII (times) | 670.18x | |
| Small NII (times) | 451.35x | |
| RII (times) | 401.36x | 1.32x |
| Employee (times) | 0.00x | |
| Other (times) | ||
| Total (times) | 270.19x | 1.26x |
